GB Sciences (GBLX) S-1/A 6 Oct 14 2015 FY IPO registration (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Aug. 12, 2014
Document and Entity Information:	'	'	'
Entity Registrant Name	'Growblox Sciences, Inc.	'	'
Document Type	'S-1	'	'
Document Period End Date	30-Jun-14	'	'
Amendment Flag	'false	'	'
Entity Central Index Key	'0001165320	'	'
Current Fiscal Year End Date	'--03-31	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Current Reporting Status	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Common Stock, Shares Outstanding	'	'	32,473,282
Document Fiscal Year Focus	'2015	'	'
Document Fiscal Period Focus	'FY	'	'
Date of Incorporation	4-Apr-01	4-Apr-01	'

Condensed_Balance_Sheets

Condensed Balance Sheets (USD $)	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
Current assets:	'	'	'
Cash	$3,213,358	$339,327	$2,427
Subscription Receivable	'	150,000	'
Inventory	3,000	'	'
Debt issuance costs	'	'	3,963
Prepaid expenses and other current assets	17,664	'	100
Total current assets	3,234,022	489,327	6,490
Property and Equipment, net	74,021	44,922	128
Intangibles, net	3,675	3,735	'
Total property and equipment	77,696	48,657	128
Total assets	3,311,718	537,984	6,618
Current liabilities:	'	'	'
Accounts payable	33,862	19,762	11,886
Subscriptions payable	35,250	10,000	'
Accrued interest	108,749	252,304	208,088
Other accrued expenses	1,847	1,847	45,751
Notes from shareholders	5,000	5,000	'
Convertible notes from shareholders	368,610	1,262,441	442,750
Convertible notes from shareholders, at fair value	'	'	227,521
Derivative liability, at fair value	'	0	260,311
Total current liabilities	553,318	1,551,354	1,196,307
Commitments and contingencies	'	'	'
Stockholders' equity (deficiency):	'	'	'
Common stock, $0.0001 par value, 250,000,000 shares authorized 32,473,282, 7,268,948 and 850,110 shares issued and outstanding at June 30, 2014, March 31, 2014 and March 31, 2013	3,247	727	85
Additional paid-in capital	10,350,432	5,198,659	4,367,028
Accumulated deficit	-7,657,974	-6,212,756	-5,556,802
Total stockholders' equity (deficiency)	2,695,705	-1,013,370	-1,189,689
Noncontrolling interest	62,695	'	'
Total equity	2,758,400	-1,013,370	-1,189,689
Total liabilities and stockholders' equity (deficiency)	$3,311,718	$537,984	$6,618

Condensed_Balance_Sheets_Paren

Condensed Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
Statement Of Financial Position	'	'	'
Common stock, par or stated value	$0.00	$0.00	$0.00
Common stock, shares authorized	250,000,000	250,000,000	250,000,000
Common stock, shares issued	32,473,282	7,268,948	850,110
Common Stock, shares outstanding	32,473,282	7,268,948	850,110

Statement_of_Operations

Statement of Operations (USD $)	3 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2013
Income Statement	'	'	'	'
Net revenue	'	'	'	'
Cost of revenue	'	'	'	'
Gross profit (loss)	'	'	'	'
Stock compensation	537,296	'	'	'
Loss on oil and gas properties	'	'	'	36,000
Investor relations	396,000	'	'	'
General and administrative expenses	561,900	29,487	187,760	75,718
Loss from continuing operations	-1,495,196	-29,487	-187,760	-111,718
Other income/(expense)	'	'	'	'
Change in fair value of convertible notes	'	'	65,235	101,701
Change in fair value of warrants	'	'	-78,385	-97,575
Loss on extinguishment of debt	559,048	'	559,048	'
Loss on loan modification	'	'	'	'
Interest expense	'	-12,717	-52,767	-51,408
Interest income	173	'	'	'
Total other income/(expenses)	173	-12,717	-468,195	147,868
Total income/(loss)	-1,495,023	-42,204	'	36,150
Less net income (loss) attributable to noncontrolling interests	-49,805	'	'	'
Net income/(loss)	($1,445,218)	($42,204)	($655,955)	$36,150
Weighted average common shares outstanding:	'	'	'	'
Basic and diluted	3,658,004	850,110	940,723	966,858
Net income/(loss) per share	'	'	'	'
Basic and diluted	($0.40)	($0.05)	($0.70)	$0.04

Statements_of_Stockholders_Equ

Statements of Stockholders' Equity (Deficiency) (USD $)	Common Stock	Additional Paid-in Capital	Deficit Accumulated Related to Abandoned Activities	Deficit Accumulated During Exploration Stage	Total
Stockholders' Equity, beginning of period, Value at Feb. 29, 2008	$9	$1,469,728	($1,676,223)	'	($206,486)
Stockholders' Equity, beginning of period, Shares at Feb. 29, 2008	88,682	'	'	'	'
Net loss	'	'	'	-9,845	-9,845
Stockholders' Equity, end of period, Value at Mar. 31, 2008	9	1,469,728	-1,676,223	-9,845	-216,331
Stockholders' Equity, beginning of period, Shares at Mar. 31, 2008	88,682	'	'	'	'
Issuance of stock as compensation, in March 2009, Value	'	516	'	'	516
Issuance of stock as compensation, in March 2009, Shares	1,033	'	'	'	'
Loss on loan modification	'	202,500	'	'	202,500
Net loss	'	'	'	-341,967	-341,967
Stockholders' Equity, end of period, Value at Mar. 31, 2009	9	1,672,744	-1,676,223	-351,812	-355,282
Stockholders' Equity, end of period, Shares at Mar. 31, 2009	89,714	'	'	'	'
Issuance of stock for debt conversions, Value	22	21,600	'	'	21,622
Issuance of stock for debt conversions, Shares	216,225	'	'	'	'
Compensation expense - employment contracts, Value	38	1,031,002	'	'	1,031,040
Compensation expense - employment contracts, Shares	387,300	'	'	'	'
Compensation expense - stock option	'	984,600	'	'	984,600
Compensation expense - consulting, Value	1	89,256	'	'	89,257
Compensation expense - consulting, Shares	8,014	'	'	'	'
Beneficial conversion features	'	133,000	'	'	133,000
Loss on loan modification	'	258,441	'	'	258,441
Net loss	'	'	'	-2,964,861	-2,964,861
Stockholders' Equity, end of period, Value at Mar. 31, 2010	70	4,190,643	-1,676,223	-3,316,673	-802,183
Stockholders' Equity, end of period, Shares at Mar. 31, 2010	701,253	'	'	'	'
Compensation expense - consulting, Value	1	62,399	'	'	62,400
Compensation expense - consulting, Shares	6,000	'	'	'	'
Legal Retainer, Value	'	10,000	'	'	10,000
Legal Retainer, Shares	2,857	'	'	'	'
Net loss	'	'	'	-585,293	-585,293
Stockholders' Equity, end of period, Value at Mar. 31, 2011	710	4,263,042	-1,676,223	-3,901,966	-1,315,076
Stockholders' Equity, end of period, Shares at Mar. 31, 2011	710,110	'	'	'	'
Compensation - employment contracts, Value	240	-240	'	'	'
Compensation - employment contracts, Shares	2,402,682	'	'	'	'
Issuance of stock for debt conversions, Value	14	103,986	'	'	104,000
Issuance of stock for debt conversions, Shares	140,000	'	'	'	'
Net loss	'	'	'	-14,763	-14,763
Stockholders' Equity, end of period, Value at Mar. 31, 2012	3,253	4,363,860	-1,676,223	-3,916,729	-1,225,839
Stockholders' Equity, end of period, Shares at Mar. 31, 2012	32,527,930	'	'	'	'
Compensation - employment contracts, Value	-240	240	'	'	'
Compensation - employment contracts, Shares	-2,402,682	'	'	'	'
Sale of stock subscription	1	11,499	'	'	12,500
Return of stock sold	-1	-11,499	'	'	-12,500
Rounding	1	'	'	'	'
Issuance of stock for debt conversions, Shares	'	'	'	'	438,681
Net loss	'	'	'	36,150	36,150
Stockholders' Equity, end of period, Value at Mar. 31, 2013	85	4,367,028	-1,676,223	-3,880,579	-1,189,689
Stockholders' Equity, end of period, Shares at Mar. 31, 2013	850,110	'	'	'	'
Fractional share from stock split, Shares	157	'	'	'	'
Asset acquisition, Value	450	33,317	'	'	33,467
Asset acquisition, Shares	4,500,000	'	'	'	'
Sale of stock subscription, Value	148	739,852	'	'	740,000
Sale of stock subscription	1,480,000	'	'	'	'
Rounding	'	-1	'	1	'
Issuance of stock for debt conversions, Value	44	114,013	'	'	114,057
Issuance of stock for debt conversions, Shares	438,681	'	'	'	'
Stock issuance costs	'	-55,250	'	'	-55,250
Net loss	'	'	'	-655,955	-655,955
Stockholders' Equity, end of period, Value at Mar. 31, 2014	727	5,615,193	-1,676,223	-4,536,533	-1,013,370
Stockholders' Equity, end of period, Shares at Mar. 31, 2014	7,268,948	'	'	'	'
Compensation - employment contracts, Value	'	'	'	'	252,304
Issuance of stock for debt conversions, Value	'	'	'	'	893,831
Issuance of stock for debt conversions, Shares	3,905,612	'	'	'	'
Net loss	'	'	'	'	-1,445,218
Stockholders' Equity, end of period, Value at Jun. 30, 2014	'	'	'	'	$2,695,705

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	3 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'	'	'
Net loss	($1,445,218)	($42,204)	($655,955)	$36,150
Less net loss attributable to noncontrolling interest	-49,805	'	'	'
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'	'
Depreciation expense	227	75	128	300
Amortization expense	60	'	10	'
Loss on oil and gas assets	'	'	'	36,000
Stock compensation	537,296	'	'	'
Loss on loan modification	'	'	'	'
Loss on extinguishment of debt	559,048	'	559,048	'
Change in fair value of convertible notes	'	'	-65,235	-101,701
Change in fair value of warrants	'	'	-78,385	-97,575
Non-cash interest	'	1,694	8,552	7,317
Changes in operating assets and liabilities:	'	'	'	'
Inventory	-3,000	'	'	'
Prepaid expenses	-13,563	'	'	'
Other assets	-4,100	'	'	350
Accounts payable	14,100	10,825	7,875	5,327
Stock subscription payable	25,250	'	10,000	'
Accrued expenses	'	18,705	312	76,385
Net cash used in operating activities	-938,753	-10,905	-213,650	-37,447
Cash flows from investing activities:	'	'	'	'
Investment in oil and gas properties	'	'	'	'
Purchase of property and equipment	-29,326	'	-15,200	'
Net cash used in investing activities	-29,326	'	-15,200	'
Cash flows from financing activities:	'	'	'	'
Stock subscription receivable	150,000	'	-150,000	'
Proceeds from issuance of stock	3,579,612	'	684,750	'
Proceeds from noncontrolling interest	112,500	'	'	'
Proceeds from issuance of debt to stockholders	'	26,000	31,000	37,700
Net cash provided by financing activities	3,842,112	26,000	715,750	37,700
Net increase (decrease) in cash	2,874,031	15,095	336,900	253
Cash, beginning of year	339,327	2,427	2,427	2,174
Cash, end of year	3,213,358	17,522	339,327	2,427
Non-cash investing and financing activities:	'	'	'	'
Stock issued to settle convertible debt	893,831	'	114,057	'
Stock issued to settle interest expense	$143,555	'	'	'

Organization_and_Principles_of

Organization and Principles of Consolidation	3 Months Ended
	Jun. 30, 2014
Notes	'
Organization and Principles of Consolidation	'
	NOTE 1 - ORGANIZATION AND PRINCIPLES OF CONSOLIDATION
	(For The Year Ended March 31, 2014)
	Reporting Entity. GrowBlox Sciences, Inc.  (“GrowBlox” or “the Company”) was incorporated on April 4, 2001 under the laws of the State of Delaware. The Company is authorized to issue 250,000,000 shares of common stock, par value $.0001. On March 18, 2014, we purchased assets from Craig Ellins, which included the revolutionary GrowBLOX technology. We plan to utilize this technology to commercially cultivate and produce medical grade cannabis for sale in the U.S. states and territories in which it is legal. We also plan to research the medical treatment potential of cannabis and develop treatments from those findings. On April 4, 2014, we officially changed our name to GrowBLOX Sciences, Inc. to reflect this new corporate direction.   The Company’s office is located in Las Vegas, Nevada.
	NOTE 1 - ORGANIZATION AND PRINCIPLES OF CONSOLIDATION
	(For the Three Months Ended June 30, 2014)
	The accompanying unaudited condensed financial statements have been prepared by the Company, pursuant to the rules and regulations of the U. S. Securities and Exchange Commission for Form 10-Q.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading.  The unaudited condensed financial statements included herein reflect all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position and operating results for the interim period.  Interim results are not necessarily indicative of the results that may be expected for the year.  The unaudited condensed financial statements should be read in conjunction with the condensed financial statements and notes thereto, together with management’s discussion and analysis of financial condition and results of operation, for the year ended March 31, 2014, contained in the Company’s March 31, 2014 Annual Report on Form 10-K.
	The Company’s consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced net losses since April 4, 2001 which losses have caused an accumulated deficit of approximately $7,600,000 as of June 30, 2014. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.
	Management has been able, thus far, to finance the losses through a public offering, private placements and obtaining operating funds from stockholders. The Company is continuing to seek sources of financing.  There are no assurances that the Company will be successful in achieving its goals.
	In view of these conditions, the Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing or capital sources, to meet its financing requirements, and ultimately to achieve profitable operations. The Company is currently in the process of acquiring and developing crude oil and natural gas leases. Management believes that its current and future plans provide an opportunity to continue as a going concern. The accompanying condensed financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that may be necessary in the event the Company cannot continue as a going concern.

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Jun. 30, 2014
Notes	'
Basis of Presentation	'
	NOTE 2 - BASIS OF PRESENTATION
	(For The Year Ended March 31, 2014)
	The Company’s financial statements have been prepared assuming the Company will continue as a going concern. The Company has experienced net losses since April 4, 2001, which losses have caused an accumulated deficit of approximately $6,100,000 at March 31, 2014 of which $4,500,000  has been accumulated during our current development activities. In addition, the Company has consumed cash in its operating activities of approximately $364,000 and $37,000 for the years ended March 31, 2014 and 2013, respectively. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.
	Management has been able, thus far, to finance the losses through a public offering, private placements and obtaining operating funds from stockholders. The Company is continuing to seek sources of financing.  There are no assurances that the Company will be successful in achieving its goals.
	In view of these conditions, the Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing or capital sources, to meet its financing requirements, and ultimately to achieve profitable operations. The Company is currently acquiring and developing crude oil and natural gas leases.   Management believes that its current and future plans provide an opportunity to continue as a going concern. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that may be necessary in the event the Company cannot continue as a going concern.
	NOTE 2 - BASIS OF PRESENTATION
	(For the Three Months Ended June 30, 2014)
	Reporting Entity. GrowBlox Sciences, Inc.  (“GrowBlox” or “the Company”) was incorporated on April 4, 2001 under the laws of the State of Delaware. The Company is authorized to issue 250,000,000 shares of common stock, par value $.0001. On March 18, 2014, we purchased assets from Craig Ellins, which included the revolutionary GrowBLOX technology. We plan to utilize this technology to commercially cultivate and produce medical grade cannabis for sale in the U.S. states and territories in which it is legal. We also plan to research the medical treatment potential of cannabis and develop treatments from those findings. On April 4, 2014, we officially changed our name to GrowBLOX Sciences, Inc. to reflect this new corporate direction.  The Company’s office is located in Las Vegas, Nevada.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Jun. 30, 2014
Notes	'
Summary of Significant Accounting Policies	'
	NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Development Stage Company. The Company is considered to be in the development stage.
	Cash and Cash Equivalents. The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
	Revenue Recognition. The Company will recognize revenue when the following conditions have been met:
	1. Persuasive evidence of an arrangement exits,
	2. Delivery has occurred, or services have been rendered,
	3. The price is fixed or determinable, and
	4. Collectability is reasonably assured.
	The Company had no revenue during the period.
	Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Property and Equipment. Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets: 3-8 years for machinery and equipment, leasehold improvements are amortized over the shorter of the estimated useful lives or the underlying lease term. Repairs and maintenance expenditures which do not extend the useful lives of related assets are expensed as incurred.
	Income Taxes.  The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in financial statements or tax returns. Deferred tax items are reflected at the enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.   Due to the uncertainty regarding the success of future operations, management has valued the deferred tax asset allowance at 100% of the related deferred tax assets.
	Loss per Share. The Company’s basic loss per share has been calculated using the weighted average number of common shares outstanding during the period. The Company has 8,757,106 potentially dilutive common shares at March 31, 2014.  However, such common stock equivalents were not included in the computation of diluted net loss per share as their inclusion would have been anti-dilutive.
	Fair Value Measurement. ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability. The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:
	Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.
	Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
	Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 fair value elections are made on an instrument by instrument basis.
	In accordance with the fair value accounting requirements, companies may choose to measure eligible financial instruments and certain other items at fair value. The Company has not elected the fair value option for any eligible financial instruments.
	Recent Accounting Pronouncements
	There were no recently issued accounting pronouncements that will have a material impact on the Company’s financial statements

Fair_Value_Measurements

Fair Value Measurements	3 Months Ended
	Jun. 30, 2014
Notes	'
Fair Value Measurements	'
	NOTE 4 - FAIR VALUE MEASUREMENTS
	(For The Year Ended March 31, 2014)
	The Company holds certain financial liabilities that are measured at fair value on a recurring basis in accordance with ASC Topic 825-10-15.   ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability. The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:
	Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.
	Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
	Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 fair value elections are made on an instrument-by-instrument basis. The Company uses Level 3 inputs to value convertible notes and detachable warrants accounted for as derivatives.
	The tables below detail the Company’s assets and liabilities measured at fair value.
		Fair Value Measurements March 31, 2014
		Level 1	Level 2	Level 3	Total
	Convertible notes from stockholders, at fair value	$-	$-	$-	$-
	Derivative liability	$-	$-	$-	$-
		Fair Value Measurement March 31, 2013
		Level 1	Level 2	Level 3	Total
	Convertible notes from stockholders, at fair value	$-	$-	$227,521	$227,521
	Derivative liability	$-	$-	$260,311	$260,311
	The following table presents the changes in Level 3 instruments measured on a recurring basis for the years ended March 31, 2014 and 2013:
		Convertible Notes	Derivative Liability	Total
	Balance, March 31, 2012	$308,255	$334,497	$308,255
	Realized and unrealized gains (losses); Included in other income (expense)	-101,701	-97,575	-199,276
	Purchases, issuances, and settlements	20,967	23,389	(44,356
	Balance, March 31, 2013	$227,521	$260,311	$487,832
	Realized and unrealized gains (losses); Included in other income (expense)	65,235	78,385	143,720
	Loss on extinguishment of debt	756,719	-197,671	559,048
	Purchases, issuances, and settlements	14,843	15,745	30,588
	Balance, March 31, 2014	$933,748	$-	$933,748
	The convertible notes and derivative liability in the preceding tables were measured at fair value, in accordance with ASC Topic 825-10-15, as one instrument and that fair value was allocated to each component.  The Company made the fair value election due to this methodology providing a fairer representation of the economic substance of the transaction within the fair value hierarchy. Due to the lack of relevant and market reflective Level 1 and Level 2 inputs, the Company valued the instruments using Level 3 inputs, which require significant judgment and estimates on behalf of management in developing model assumptions. The factors considered in developing those assumptions included; the Company’s inability to attract investment at terms more favorable to the Company, the lack of success in developing oil properties thus far, the continuing reduction in the net assets of the Company and the Company’s history of default on currently outstanding debt.
	Based on management’s evaluation of the assumptions discussed above, the liabilities were initially recorded in an amount equal to the transaction price, which represented the fair value of the total liability at initial recognition. The model used by the Company is calibrated so that the model value at initial recognition equals the transaction price. On an ongoing basis the fair value model used in valuing the convertible notes and derivative liability utilizes the following inputs; exercise price per warrant, conversion price per share, contract term, volatility, current stock prices and risk free rates. The following assumptions were made in the model (1) risk free interest rate of 0.18% to 0.63%, (2) remaining contractual life of 1 to 4.87 years, (3) expected stock price volatility of 797% and (4) expected dividend yield of zero.
	In March 2014, the note holders’ agreed to modify the terms of the notes and warrants.  The notes are now convertible at a fixed price of $0.26.  The notes will no longer be carried at fair market value using Level 3 inputs now that the conversion price is a fixed amount.   The warrants have been cancelled and no longer have any value.  A loss of $559,048 for the extinguishment of debt has been recorded on the Statement of Operations as of March 31, 2014.
	The following table presents the change due to the modified terms:
		Convertible Notes	Derivative Liability	Total
	Balance at Fair Value, March 31, 2013	$227,521	$260,311	$487,832
	Realized and unrealized gains (losses);	-65,235	-78,385	-143,720
	Included in other income (expense)	756,719	-197,671	559,048
	Purchases, issuances, and settlements	14,743	15,745	30,488
	Balance, March 31, 2014	$933,748	$-	$933,748
	The Company applied ASC 470-50-40/55 -Debtor’s Accounting for a Modification or Exchange of Debt Instrument and concluded that the Third Amendment Agreement constituted a debt extinguishment rather than debt modification because the change in the fair value of the embedded conversion features immediately before and after the modification exceeded 10% of the original loan balance. As a result, the Company recorded a loss on debt extinguishment of $559,048 during the year ended March 31, 2014, as summarized below:
	Loss on Extinguishment:
	Carrying value of pre-modification debt	$487,832
	Less: Estimated fair value of debt after modification	-933,748
	Original issue discount	-
	Fair value of assets given	-113,132
	Loss on debt extinguishment	($559,048)

Deferred_Income_Taxes

Deferred Income Taxes	3 Months Ended
	Jun. 30, 2014
Notes	'
Deferred Income Taxes	'
	NOTE 5 - DEFERRED INCOME TAXES
	(For The Year Ended March 31, 2014)
	At March 31, 2014, the Company had net operating loss carryforwards for income tax purposes of approximately $4,413,000 available as offsets against future taxable income.  The net operating loss carryforwards are expected to expire at various times from 2024 through 2032. Utilization of the Company’s net operating losses may be subject to substantial annual limitation if the Company experiences a 50% change in ownership, as provided by the Internal Revenue Code and similar state provisions.  Such an ownership change would substantially increase the possibility of net operating losses expiring before complete utilization.
	The tax effects of the primary temporary differences giving rise to the Company’s deferred tax assets and liabilities are as follows for the year ended March 31, 2014:
		2014	2013
	Deferred tax assets:
	Net operating loss carryforward	$1,674,000	$1,583,000
	Stock based compensation	-	-
	Total deferred tax assets	1,674,000	1,583,000
	Less valuation allowance	(1,674,000	(1,583,000
	Net deferred tax asset	$-	$-
	Because of the Company’s lack of earnings history, the deferred tax assets have been fully offset by a valuation allowance. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during those periods that the temporary differences become deductible. The Company believes that the tax positions taken in its tax returns would be sustained upon examination by taxing authorities. During the year ended March 31, 2014, the decrease in the deferred tax asset valuation allowance amounted to approximately $91,000.
	The provision for income taxes is different than would result from applying the U.S. statutory rate to profit before taxes for the reasons set forth in the following reconciliation:
		2014	2013
	Tax benefit computed at U.S. statutory rates	($229,000)	($205,000)
	Increases (decreases) in taxes resulting from:
	Non-deductible items	145,000	22,000
	Change in valuation allowance	91,000	198,000
	State taxes	-7,000	-15,000
	Total	$-	$-
	As a result of the implementation of certain provisions of ASC 740, Income Taxes, the Company performed an analysis of its previous tax filings and determined that there were no positions taken that it considered uncertain. Therefore, there were no unrecognized tax benefits as of March 31, 2013 and 2012.  The open tax years for each Federal taxes are March 31, 2011-2014.

Convertible_Notes_and_Warrants

Convertible Notes and Warrants	3 Months Ended
	Jun. 30, 2014
Notes	'
Convertible Notes and Warrants	'
	NOTE 6 - CONVERTIBLE NOTES AND WARRANTS
	(For the Year Ended March 31, 2014)
	Convertible Notes from Shareholders
	The Company has debt outstanding to shareholders, which was issued between 2006 and 2009. The debt was not issued with warrants and some of the debt was not originally issued with a conversion feature. During fiscal years 2009 and 2010, the notes without conversion features were modified to contain a conversion feature, for which the Company recorded a loss on the modification.  Convertible notes from shareholders issued during fiscal year 2010 contained a beneficial conversion feature, with the discount being amortized over the term of the note, see table below.
		For the year ended March 31, 2014		For the year ended March 31, 2013
		Convertible Notes	Accrued Interest	Convertible Notes	Accrued Interest
	Balance, beginning of period	$442,750	$208,088	$446,750	$163,998
	Conversion to common stock	-114,057	-	-	-
	Reclassified from Convertible Notes at Fair Value	933,748	-	-	-
	Accrued interest	-	44,216	-	44,090
	Balance, end of period	$1,262,441	$252,304	$442,750	$208,088
	Convertible notes from shareholders accrued interest at a rate of 10 percent per annum. The note holders had the sole option of converting the principal and interest represented by these notes into our common stock at a strike price equal to a $0.01. The note holders were only be allowed to convert shares or portion thereof to the extent that, at the time of the conversion, the conversion will not result in the note holders beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.
	In March 2014, the note holders agreed to modify the terms of the notes.  The notes are now convertible at a fixed price of $0.26 and interest will no longer accrue on the remaining notes.  The note holders were only be allowed to convert shares or portion thereof to the extent that, at the time of the conversion, the conversion will not result in the note holders beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.
		Warrants Outstanding
		Number of Shares	Exercise Price
	Outstanding at March 31, 2012	11,921,206	$0.15-$0.10
	Warrants issued	443,560	$0.15
	Warrants exercised	-	-
	Warrants expired/cancelled	-	-
	Outstanding at March 31, 2013	12,364,766	$0.15-$0.10
	Warrants issued	2,960,000	$1.00-$2.00
	Warrants exercised	-	-
	Warrants expired/cancelled	-12,364,766	-
	Outstanding at March 31, 2014	2,960,000	$1.00-$2.00
	NOTE 4 - CONVERTIBLE NOTES AND WARRANTS
	(For the Three Months Ended June 30, 2014)
	Convertible Notes from Shareholders
	The Company has debt outstanding to shareholders, which was issued between 2006 and 2013. The debt was not issued with warrants and some of the debt was not originally issued with a conversion feature. During fiscal years 2009 and 2010, the notes without conversion features were modified to contain a conversion feature, for which the Company recorded a loss on the modification.  Convertible notes from shareholders issued during fiscal year 2010 contained a beneficial conversion feature, with the discount being amortized over the term of the note.
	Convertible notes from shareholders accrued interest at a rate of 10 percent per annum. The note holders had the sole option of converting the principal and interest represented by these notes into our common stock at a strike price equal to a $0.01. The note holders were only be allowed to convert shares or portion thereof to the extent that, at the time of the conversion, the conversion will not result in the note holders beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.
	Additional, between December, 2009 and February, 2013, the Company entered into several Convertible Note Agreements ("Notes") for a total of $1,033,744.  The Company received aggregate proceeds of $884,700 reflecting a 15% original issue discount to the Note holders and a nominal rate of 16.63%.
	The Notes were due after one year.  The note holders could have converted any portion of the Notes that are outstanding, whether such portion represents principal or interest, into shares of common stock of the Company at a price equal to $0.10. The Notes includes an anti-dilution adjustment that may not be adjusted below $0.01.
	Simultaneously with the issuance of these Notes, the Company issued to the Note holders a 5-year warrant (the "Warrants") to purchase 12,364,766 shares of common stock of the Company.  The Warrants were exercisable at a price equal to $0.15. The Warrants included an anti-dilution adjustment that may not be adjusted below $0.01.
	The note holders were only be allowed to convert shares or exercise warrants or portion thereof to the extent that, at the time of the conversion or exercise, the conversion or exercise will not result in the note holder beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.
	Simu ltaneously with the issuance of this Note, the Company issued to each Note holder a 5-year warrant (the "Warrant") to purchase 504,203 shares of common stock of the Company.  The Warrant is exercisable at a price equal to $0.50. The Warrants include an anti-dilution adjustment that may not be adjusted below $0.01.
	The note holder will only be allowed to convert shares or exercise warrants or portion thereof to the extent that, at the time of the conversion or exercise, the conversion or exercise will not result in the note holder beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.
	In March 2014, the note holders’ agreed to modify the terms of all the notes and warrants.  The notes are now convertible at a fixed price of $0.26.  The warrants have been cancelled and no longer have any value.  A loss of $559,048 for the extinguishment of debt has been recorded on the State of Operations as of March 31, 2014.
		For the three months ended June 30, 2014		For the year ended March 31, 2014
		Convertible Notes	Accrued Interest	Convertible Notes	Accrued Interest
	Balance, beginning of period	$1,262,441	$252,304	$1,376,228	$208,088
	Conversion to common stock	893,831	252,304	114,057	-
	Accrued interest	-	-	-	44,216
	Balance, end of period	$368,610	$108,749	$1,262,441	$252,304
		Warrants Outstanding
		Number of Shares	Exercise Price
	Outstanding at March 31, 2013	12,364,766	0.15-$0.10
	Warrants issued	2,960,000	1.00-$2.00
	Warrants exercised	-	-
	Warrants expired/cancelled	-12,364,766	-
	Outstanding at March 31, 2014	2,960,000	1.00-$2.00
	Warrants issued	12,038,446	0.55-$2.00
	Warrants exercised	-	-
	Warrants expired/cancelled	-	-
	Outstanding at June 30, 2014	14,995,446	0.55-$2.00

Stockholders_Equity_capital_De

Stockholders' Equity (capital Deficiency)	3 Months Ended
	Jun. 30, 2014
Notes	'
Stockholders' Equity (capital Deficiency)	'
	NOTE 7 - CAPITAL TRANSACTIONS
	(For the Year Ended March 31, 2014)
	Sale of Common Stock
	As of March 31, 2014, the Company sold 1,480,000 units through a private placement.   Each unit consists of one share of common stock, one A warrant, expiring in three years, with an exercise price of $1.00 and one B warrant, expiring in five years, with an exercise price of $2.00. The price was $0.50 per unit.
	Asset Purchase
	On March 13, 2014, the Company, entered into a definitive agreement with Mr. Craig Ellins for the acquisition of assets The Assets include:
	•	a provisional patent application
	•	concepts associated with the Mr. Ellins or his associates
	•	trademarks
	•	business plans
	•	investor presentations and histories
	•	websites
	•	trade secrets including without limitation trade secrets involving nutrient mixes
	•	drawings and digital artwork
	•	raw materials
	•	production equipment and related assets including without limitation electrical equipment, plastic molds and internal parts
	•	proof-of-concept equipment
	•	URL’s
	In exchange for the Assets, the Company agreed to issue 12,500,000 restricted shares of the Company’s common stock.  Of the total number of shares to be issued, 4,500,000 were issued upon the signing of the Agreement.  The remainder of the shares will be issued upon reaching certain milestones.  The shares were issued pursuant to the exemption from registration set forth in Section 4(2) of the Securities Act of 1933.
	Below are the assets purchased:
	Equipment	$29,722
	Intangibles (patent, trademarks, URL’s)	3,735
	Total	$33,457
	The assets were valued at their historical cost.
	Employment Agreements
	Mr. Alan Gaines, our former Chief Executive Officer and Chairman, had entered into an Employment Agreement with the Company for a one-year term beginning May 2, 2011.  Mr. Gaines would have been compensated with 12,012,413 shares of restricted common stock, payable upon the completion of a Qualified Acquisition or Qualified Equity Raise.  An expense of $960,993 would have been recorded as stock compensation at the time a Qualified Acquisition or Qualified Equity Raise is completed.  Upon the resignation of Mr. David on April 18, 2012, the shares were canceled and no expense was recognized.
	Dr. Amiel David, our former Chief Operating Officer, has entered into an Employment Agreement with the Company for a one-year term beginning May 2, 2011. Dr. David would have been compensated with 12,013,413 shares of restricted common stock, payable upon the completion of a Qualified Acquisition or Qualified Equity Raise.  An expense of $961,073 would have been recorded as stock compensation at the time a Qualified Acquisition or Qualified Equity Raise is completed.  Upon the resignation of Mr. David on April 18, 2012, the shares were canceled and no expense was recognized.
	Note Conversions
	During the year ended March 31, 2014, the Company converted a total of $114,013 of notes payable from certain Note Holders into common stock of the Company.  The Company issued 438,681 shares of our common stock to satisfy the principal balances of the notes payable.
	NOTE 5 - STOCKHOLDERS’ EQUITY (CAPITAL DEFICIENCY)
	(For the Three Months Ended June 30, 2014)
	From April 2014 to June 2014, the Company converted a total of $1,015,459 of notes payable from certain Note Holders into common stock of the Company.  The Company issued 3,905,612 shares of our common stock to satisfy the principal and interest balances of the notes payable.
	As of June 30, 2014, the Company sold 4,520,000 units through a private placement.   Each unit consists of one share of common stock, one A warrant, expiring in three years, with an exercise price of $1.00 and one B warrant, expiring in five years, with an exercise price of $2.00. The price was $0.50 per unit.
	On March 13, 2014 the Company entered into a definitive agreement (the “Agreement”) with Mr. Craig Ellins for the acquisition of assets.  In accordance with the Agreement, Mr. Ellins was issued an additional four million shares upon the completion of a minimum of $1,000,000 in proceeds to the Company from fund raising on May 1, 2014.  The shares were issued pursuant to the exemption from registration set forth in Section 4(2) of the Securities Act of 1933.
	On June 27, 2014, the Company issued 8,950,000 shares of common stock pursuant to the employment contracts of our three executive officers valued at $1.24 per share.   Fifty thousand of the shares were paid directly to one of the officers.  The remaining shares will be held by the Company until such time as certain milestones are reached and vesting periods have run.  The issuance was exempt from the registration requirements of Section 5 of the Securities Act of 1933 pursuant to Section 4(2) of the Act because there was no public offering in connection with the issuance of the shares.

Stock_Option_Plan

Stock Option Plan	3 Months Ended
	Jun. 30, 2014
Notes	'
Stock Option Plan	'
	NOTE 8 - STOCK OPTION PLAN
	(For The Year Ended March 31, 2014)
	On February 6, 2008, the Board of Directors adopted the GrowBlox Sciences, Inc. 2007 Amended Stock Option Plan (“2007 Plan”).  Under the 2007 Plan, 8,000,000 shares of the Company’s restricted common stock may be issuable upon the exercise of options issued to employees, advisors and consultants.
	At March 31, 2014 the Company has no stock options outstanding.

Subsequent_Events

Subsequent Events	3 Months Ended
	Jun. 30, 2014
Notes	'
Subsequent Events	'
	NOTE 9 - SUBSEQUENT EVENT
	(For The Year Ended March 31, 2014)
	From April 2014 to June 2014, the Company converted a total of $1,015,459 of notes payable from certain Note Holders into common stock of the Company.  The Company issued 3,905,612 shares of our common stock to satisfy the principal balances of the notes payable.
	As of June 21, 2014, the Company sold 4,520,000 units through a private placement.   Each unit consists of one share of common stock, one A warrant, expiring in three years, with an exercise price of $1.00 and one B warrant, expiring in five years, with an exercise price of $2.00. The price was $0.50 per unit.
	On March 13, 2014 the Company entered into a definitive agreement (the “Agreement”) with Mr. Craig Ellins for the acquisition of assets.  In accordance with the Agreement, Mr. Ellins was issued an additional four million shares upon the completion of a minimum of $1,000,000 in proceeds to the Company from fund raising on May 1, 2014.  The shares were issued pursuant to the exemption from registration set forth in Section 4(2) of the Securities Act of 1933.
	Subsequent to the fiscal year ended March 31, 2014, the Company issued 8,950,000 shares of common stock pursuant to the employment contracts of our three executive officers.  Fifty thousand of the shares were paid directly to one of the officers.  The remaining shares will be held by the Company until such time as certain milestones are reached and vesting periods have run.  The issuance was exempt from the registration requirements of Section 5 of the Securities Act of 1933 pursuant to Section 4(2) of the Act because there was no public offering in connection with the issuance of the shares.
	NOTE 6 - SUBSEQUENT EVENTS
	(For the Three Months Ended June 30, 2014)
	On July 15, 2014 the Company converted a total of $307,356 of notes payable from certain Note Holders into common stock of the Company.  The Company issued 1,202,500 shares of our common stock to satisfy the principal and interest balances of the notes payable.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Jun. 30, 2014
Policies	'
Development Stage Company	'
	Development Stage Company. The Company is considered to be in the development stage.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents. The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
Revenue Recognition	'
	Revenue Recognition. The Company will recognize revenue when the following conditions have been met:
	1. Persuasive evidence of an arrangement exits,
	2. Delivery has occurred, or services have been rendered,
	3. The price is fixed or determinable, and
	4. Collectability is reasonably assured.
	The Company had no revenue during the period.
Use of Estimates	'
	Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Property, Plant and Equipment	'
	Property and Equipment. Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets: 3-8 years for machinery and equipment, leasehold improvements are amortized over the shorter of the estimated useful lives or the underlying lease term. Repairs and maintenance expenditures which do not extend the useful lives of related assets are expensed as incurred.
Income Taxes	'
	Income Taxes.  The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in financial statements or tax returns. Deferred tax items are reflected at the enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.   Due to the uncertainty regarding the success of future operations, management has valued the deferred tax asset allowance at 100% of the related deferred tax assets.
Loss Per Share	'
	Loss per Share. The Company’s basic loss per share has been calculated using the weighted average number of common shares outstanding during the period. The Company has 8,757,106 potentially dilutive common shares at March 31, 2014.  However, such common stock equivalents were not included in the computation of diluted net loss per share as their inclusion would have been anti-dilutive.
Fair Value Measurement	'
	Fair Value Measurement. ASC Topic 820-10 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability. The three levels of the fair value hierarchy under ASC Topic 820-10 are described below:
	Level 1. Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access.
	Level 2. Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
	Level 3. Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 fair value elections are made on an instrument by instrument basis.
	In accordance with the fair value accounting requirements, companies may choose to measure eligible financial instruments and certain other items at fair value. The Company has not elected the fair value option for any eligible financial instruments.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	There were no recently issued accounting pronouncements that will have a material impact on the Company’s financial statements

Fair_Value_Measurements_Fair_V

Fair Value Measurements: Fair Value, Level 3 Instruments (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Fair Value, Level 3 Instruments	'
		Fair Value Measurements March 31, 2014
		Level 1	Level 2	Level 3	Total
	Convertible notes from stockholders, at fair value	$-	$-	$-	$-
	Derivative liability	$-	$-	$-	$-
		Fair Value Measurement March 31, 2013
		Level 1	Level 2	Level 3	Total
	Convertible notes from stockholders, at fair value	$-	$-	$227,521	$227,521
	Derivative liability	$-	$-	$260,311	$260,311

Fair_Value_Measurements_Fair_V1

Fair Value Measurements: Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation	'
		Convertible Notes	Derivative Liability	Total
	Balance, March 31, 2012	$308,255	$334,497	$308,255
	Realized and unrealized gains (losses); Included in other income (expense)	-101,701	-97,575	-199,276
	Purchases, issuances, and settlements	20,967	23,389	(44,356
	Balance, March 31, 2013	$227,521	$260,311	$487,832
	Realized and unrealized gains (losses); Included in other income (expense)	65,235	78,385	143,720
	Loss on extinguishment of debt	756,719	-197,671	559,048
	Purchases, issuances, and settlements	14,843	15,745	30,588
	Balance, March 31, 2014	$933,748	$-	$933,748

Fair_Value_Measurements_Fair_V2

Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	'
		Convertible Notes	Derivative Liability	Total
	Balance at Fair Value, March 31, 2013	$227,521	$260,311	$487,832
	Realized and unrealized gains (losses);	-65,235	-78,385	-143,720
	Included in other income (expense)	756,719	-197,671	559,048
	Purchases, issuances, and settlements	14,743	15,745	30,488
	Balance, March 31, 2014	$933,748	$-	$933,748

Fair_Value_Measurements_Schedu

Fair Value Measurements: Schedule of Extinguishment of Debt (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Schedule of Extinguishment of Debt	'
	Loss on Extinguishment:
	Carrying value of pre-modification debt	$487,832
	Less: Estimated fair value of debt after modification	-933,748
	Original issue discount	-
	Fair value of assets given	-113,132
	Loss on debt extinguishment	($559,048)

Deferred_Income_Taxes_Schedule

Deferred Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Schedule of Deferred Tax Assets and Liabilities	'
		2014	2013
	Deferred tax assets:
	Net operating loss carryforward	$1,674,000	$1,583,000
	Stock based compensation	-	-
	Total deferred tax assets	1,674,000	1,583,000
	Less valuation allowance	(1,674,000	(1,583,000
	Net deferred tax asset	$-	$-

Deferred_Income_Taxes_Schedule1

Deferred Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Schedule of Effective Income Tax Rate Reconciliation	'
		2014	2013
	Tax benefit computed at U.S. statutory rates	($229,000)	($205,000)
	Increases (decreases) in taxes resulting from:
	Non-deductible items	145,000	22,000
	Change in valuation allowance	91,000	198,000
	State taxes	-7,000	-15,000
	Total	$-	$-

Convertible_Notes_and_Warrants1

Convertible Notes and Warrants: Convertible Debt (Tables)	3 Months Ended					12 Months Ended
	Jun. 30, 2014					Mar. 31, 2014
Tables/Schedules	'					'
Convertible Debt	'					'
		For the three months ended June 30, 2014		For the year ended March 31, 2014			For the year ended March 31, 2014		For the year ended March 31, 2013
		Convertible Notes	Accrued Interest	Convertible Notes	Accrued Interest		Convertible Notes	Accrued Interest	Convertible Notes	Accrued Interest
	Balance, beginning of period	$1,262,441	$252,304	$1,376,228	$208,088	Balance, beginning of period	$442,750	$208,088	$446,750	$163,998
	Conversion to common stock	893,831	252,304	114,057	-	Conversion to common stock	-114,057	-	-	-
	Accrued interest	-	-	-	44,216	Reclassified from Convertible Notes at Fair Value	933,748	-	-	-
	Balance, end of period	$368,610	$108,749	$1,262,441	$252,304	Accrued interest	-	44,216	-	44,090
						Balance, end of period	$1,262,441	$252,304	$442,750	$208,088

Convertible_Notes_and_Warrants2

Convertible Notes and Warrants: Schedule of Warrant Activity (Tables)	3 Months Ended			12 Months Ended
	Jun. 30, 2014			Mar. 31, 2014
Tables/Schedules	'			'
Schedule of Warrant Activity	'			'
		Warrants Outstanding			Warrants Outstanding
		Number of Shares	Exercise Price		Number of Shares	Exercise Price
	Outstanding at March 31, 2013	12,364,766	0.15-$0.10	Outstanding at March 31, 2012	11,921,206	$0.15-$0.10
	Warrants issued	2,960,000	1.00-$2.00	Warrants issued	443,560	$0.15
	Warrants exercised	-	-	Warrants exercised	-	-
	Warrants expired/cancelled	-12,364,766	-	Warrants expired/cancelled	-	-
	Outstanding at March 31, 2014	2,960,000	1.00-$2.00	Outstanding at March 31, 2013	12,364,766	$0.15-$0.10
	Warrants issued	12,038,446	0.55-$2.00	Warrants issued	2,960,000	$1.00-$2.00
	Warrants exercised	-	-	Warrants exercised	-	-
	Warrants expired/cancelled	-	-	Warrants expired/cancelled	-12,364,766	-
	Outstanding at June 30, 2014	14,995,446	0.55-$2.00	Outstanding at March 31, 2014	2,960,000	$1.00-$2.00

Stockholders_Equity_capital_De1

Stockholders' Equity (capital Deficiency): Assets purchased (Tables)	3 Months Ended
	Jun. 30, 2014
Tables/Schedules	'
Assets purchased	'
	Equipment	$29,722
	Intangibles (patent, trademarks, URL’s)	3,735
	Total	$33,457

Organization_and_Principles_of1

Organization and Principles of Consolidation (Details) (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
Details	'	'	'	'
Date of Incorporation	4-Apr-01	4-Apr-01	'	'
Common stock, shares authorized	250,000,000	250,000,000	250,000,000	250,000,000
Common stock, par or stated value	$0.00	$0.00	$0.00	$0.00
Accumulated deficit	($7,657,974)	($7,657,974)	($6,212,756)	($5,556,802)

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	3 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2013
Details	'	'	'	'
Development Stage Enterprise, Deficit Accumulated During Development Stage	$4,536,533	'	'	'
Net cash used in operating activities	($938,753)	($10,905)	($213,650)	($37,447)
Common stock, shares authorized	250,000,000	'	250,000,000	250,000,000
Common stock, par or stated value	$0.00	'	$0.00	$0.00

Summary_of_Significant_Account2

Summary of Significant Accounting Policies: Loss Per Share (Details) (Common Stock)	12 Months Ended
	Mar. 31, 2014
Common Stock	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8,757,106

Fair_Value_Measurements_Fair_V3

Fair Value Measurements: Fair Value, Level 3 Instruments (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Convertible notes from stockholders, at fair value	$0	'
Derivative Liability	0	260,311
Convertible notes from shareholders, at fair value	'	227,521
Fair Value, Inputs, Level 1	'	'
Convertible notes from stockholders, at fair value	0	'
Derivative Liability	0	0
Convertible notes from shareholders, at fair value	'	0
Fair Value, Inputs, Level 2	'	'
Convertible notes from stockholders, at fair value	0	'
Derivative Liability	0	0
Convertible notes from shareholders, at fair value	'	0
Fair Value, Inputs, Level 3	'	'
Convertible notes from stockholders, at fair value	0	'
Derivative Liability	0	260,311
Convertible notes from shareholders, at fair value	'	$227,521

Fair_Value_Measurements_Fair_V4

Fair Value Measurements: Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation (Details) (USD $)

3 Months Ended

6 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

Jun. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Jun. 30, 2014

Mar. 31, 2014

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Jun. 30, 2014

Mar. 31, 2014

Scenario, Previously Reported

Scenario, Previously Reported

Convertible Notes

Convertible Notes

Convertible Notes

Convertible Notes

Convertible Notes

Convertible Notes

Convertible Notes

Derivative Liability

Derivative Liability

Derivative Liability

Derivative Liability

Derivative Liability

Derivative Liability

Scenario, Previously Reported

Scenario, Previously Reported

Scenario, Previously Reported

Scenario, Previously Reported

Fair Value of Instruments

'

'

$933,748

$487,832

$308,255

'

'

'

$933,748

$933,748

$227,521

$308,255

'

'

'

$0

$260,311

$334,497

'

'

Realized and unrealized gains (losses); Included in other income (expense)

'

'

-143,720

-199,276

'

'

143,720

'

'

-65,235

-101,701

'

'

65,235

'

-78,385

-97,575

'

'

78,385

Purchases, issuances, and settlements

'

'

30,488

-44,356

'

'

30,588

'

'

14,743

20,967

'

'

14,843

'

15,745

23,389

'

'

15,745

Loss on debt extinguishment

($559,048)

($559,048)

($559,048)

'

'

$559,048

'

($756,719)

$559,048

'

'

'

$756,719

'

$197,671

'

'

'

($197,671)

'

Fair_Value_Measurements_Detail

Fair Value Measurements (Details) (USD $)	3 Months Ended
	Jun. 30, 2014
Expected Stock Price Volatility Rate	797.00%
Expected Dividend Yield	0.00%
Debt Instrument, Convertible, Conversion Price	$0.26
Minimum	'
Risk Free Interest Rate	0.18%
Remaining Contractual Life	'1 year
Maximum	'
Risk Free Interest Rate	0.63%
Remaining Contractual Life	'4 years 10 months 13 days

Fair_Value_Measurements_Fair_V5

Fair Value Measurements: Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) (USD $)

3 Months Ended

6 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

Jun. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Convertible Notes

Convertible Notes

Convertible Notes

Convertible Notes

Convertible Notes

Derivative Liability

Derivative Liability

Derivative Liability

Derivative Liability

Fair Value of Instruments

'

'

$933,748

$487,832

$308,255

'

$933,748

$933,748

$227,521

$308,255

'

$0

$260,311

$334,497

Realized and unrealized gains (losses); Included in other income (expense)

'

'

-143,720

-199,276

'

'

'

-65,235

-101,701

'

'

-78,385

-97,575

'

Included in other income (expense)

559,048

559,048

559,048

'

'

756,719

-559,048

'

'

'

-197,671

'

'

'

Purchases, issuances, and settlements

'

'

$30,488

($44,356)

'

'

'

$14,743

$20,967

'

'

$15,745

$23,389

'

Fair_Value_Measurements_Schedu1

Fair Value Measurements: Schedule of Extinguishment of Debt (Details) (USD $)	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Details	'	'	'	'	'
Carrying value of pre-modification debt	'	'	$933,748	$487,832	$308,255
Less: Estimated fair value of debt after modification	'	'	-933,748	-487,832	-308,255
Original Issue Discount	'	'	0	'	'
Fair Value of Assets Given	-113,132	'	'	'	'
Loss on debt extinguishment	($559,048)	($559,048)	($559,048)	'	'

Deferred_Income_Taxes_Details

Deferred Income Taxes (Details) (USD $)	Jun. 30, 2014
Details	'
Operating Loss Carryforwards	$4,413,000

Deferred_Income_Taxes_Schedule2

Deferred Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Deferred tax assets:	'	'
Net operating loss carryforward	$1,674,000	$1,583,000
Stock based compensation	0	0
Total deferred tax assets	1,674,000	1,583,000
Less: Valuation Allowance	-1,674,000	-1,583,000
Net Deferred Tax Asset	$0	$0

Deferred_Income_Taxes_Schedule3

Deferred Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	3 Months Ended	12 Months Ended
	Jun. 30, 2014	Mar. 31, 2013
Details	'	'
Tax benefit computed at U.S. statutory rates	($229,000)	($205,000)
Increases (decreases) in taxes resulting from:	'	'
Non-deductible items	145,000	22,000
Change in valuation allowance	91,000	198,000
State taxes	-7,000	-15,000
Total	$0	$0

Convertible_Notes_and_Warrants3

Convertible Notes and Warrants: Convertible Debt (Details) (USD $)	3 Months Ended	12 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2010
Convertible notes from shareholders	$368,610	$1,262,441	$442,750	$446,750	'
Accrued interest	108,749	252,304	208,088	163,998	'
Conversion to common stock	-893,831	-114,057	'	-104,000	-21,622
Increase (Decrease) in Accrued Interest	'	44,216	44,090	'	'
Conversion to common stock, Convertible Notes	893,831	114,057	'	104,000	21,622
Conversion to common stock, Accrued Interest	252,304	'	'	'	'
Convertible Notes	'	'	'	'	'
Convertible notes from shareholders	'	'	933,748	'	'
Restatement Adjustment	'	'	'	'	'
Convertible notes from shareholders	'	'	1,376,228	'	'
Scenario, Previously Reported	'	'	'	'	'
Convertible notes from shareholders	'	'	$442,750	'	'

Convertible_Notes_and_Warrants4

Convertible Notes and Warrants (Details) (USD $)	3 Months Ended	6 Months Ended	12 Months Ended		39 Months Ended				3 Months Ended		12 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013	Feb. 28, 2013	Feb. 28, 2013	Feb. 28, 2013	Feb. 28, 2013	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
						Warrant	Warrant 2	Convertible Note Agreements	Convertible Notes	Convertible Notes	Convertible Notes
Convertible notes from shareholders accrued interest rate	'	'	'	'	'	'	'	'	10.00%	'	10.00%
Debt Instrument, Convertible, Terms of Conversion Feature	'	'	'	'	'	'	'	'	'The note holders were only be allowed to convert shares or portion thereof to the extent that, at the time of the conversion, the conversion will not result in the note holders beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.	'	'The note holders were only be allowed to convert shares or portion thereof to the extent that, at the time of the conversion, the conversion will not result in the note holders beneficially owning more than 9.9% of the issued and outstanding common shares of the Company.
Debt Instrument, Convertible, Conversion Price	$0.26	$0.26	'	'	'	'	'	$0.10	$0.01	$0.26	'
Debt Instrument, Face Amount	'	'	'	'	'	'	'	$1,033,744	'	'	'
Proceeds from Convertible Debt	'	'	'	'	884,700	'	'	'	'	'	'
Original Issuance Discount	15.00%	'	'	'	'	'	'	'	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	16.63%	16.63%	'	'	'	'	'	'	'	'	'
Debt Instrument, Maturity Date, Description	'	'	'	'	'	'	'	'The Notes were due after one year.	'	'	'
Anti-dilution adjustment	'	'	'	'	'	$0.01	$0.01	$0.01	'	'	'
Warrants, Issued	12,038,446	'	2,960,000	443,560	'	12,364,766	504,203	'	'	'	'
Warrants, Exercise Price	'	'	'	'	'	$0.15	$0.50	'	'	'	'
Loss on extinguishment of debt	$559,048	$559,048	$559,048	'	'	'	'	'	$756,719	($559,048)	'

Convertible_Notes_and_Warrants5

Convertible Notes and Warrants: Schedule of Warrant Activity (Details) (USD $)	3 Months Ended	12 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012
Warrants, Outstanding	14,995,446	2,960,000	12,364,766	11,921,206
Warrants, Issued	12,038,446	2,960,000	443,560	'
Warrants, Granted, Weighted Average Exercise Price	'	'	$0.15	'
Warrants, Exercised	0	0	0	'
Warrants, Exercised, Weighted Average Exercise Price	$0	$0	$0	'
Warrants, Expired	0	12,364,766	0	'
Warrants, Expirations, Weighted Average Exercise Price	$0	$0	$0	'
Warrants, Expired	0	-12,364,766	0	'
Minimum	'	'	'	'
Warrants, Weighted Average Exercise Price	$0.55	$1	$0.15	0.15
Warrants, Granted, Weighted Average Exercise Price	$0.55	$1	'	'
Maximum	'	'	'	'
Warrants, Weighted Average Exercise Price	$2	$2	$0.10	0.1
Warrants, Granted, Weighted Average Exercise Price	$2	$2	'	'

Stockholders_Equity_capital_De2

Stockholders' Equity (capital Deficiency) (Details) (USD $)	3 Months Ended	12 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2010	Mar. 31, 2009
Stock sold through private placement	'	'	12,500	'	'	'
Common stock, shares issued	32,473,282	7,268,948	850,110	'	'	'
Converted notes payable from certain Note Holders into common stock	'	'	114,013	'	'	'
Issuance of stock for debt conversions, Shares	'	'	438,681	'	'	'
Notes Payable 1	'	'	'	'	'	'
Converted notes payable from certain Note Holders into common stock	1,015,459	'	'	'	'	'
Craig Ellins	'	'	'	'	'	'
Common stock, shares issued	12,500,000	'	'	'	'	'
Craig Ellins | March 13, 2014	'	'	'	'	'	'
Common stock, shares issued	4,500,000	'	'	'	'	'
Chief Executive Officer	'	'	'	'	'	'
Restricted Common Stock forfeited	'	'	12,012,413	'	'	'
Stock Compensation Expense, forfeited	'	'	960,993	'	'	'
Chief Operating Officer	'	'	'	'	'	'
Restricted Common Stock forfeited	'	'	12,013,413	'	'	'
Stock Compensation Expense, forfeited	'	'	961,073	'	'	'
A Warrant	'	'	'	'	'	'
Warrants, Exercise Price	$1	'	'	'	'	'
B Warrant	'	'	'	'	'	'
Warrants, Exercise Price	$2	'	'	'	'	'
Common Stock	'	'	'	'	'	'
Stock sold through private placement	'	1,480,000	1	'	'	'
Equity Issuance Price	$0.50	'	'	'	'	'
Issuance of stock for debt conversions, Shares	3,905,612	438,681	'	140,000	216,225	'
Issuance of stock pursuant to employment contracts	'	'	'	'	'	1,033
Common Stock | Craig Ellins	'	'	'	'	'	'
Stock Issued During Period, Shares, Acquisitions	4,000,000	'	'	'	'	'
Stock Issued During Period, Description	'upon the completion of a minimum of $1,000,000 in proceeds to the Company from fund raising on May 1, 2014. The shares were issued pursuant to the exemption from registration set forth in Section 4(2) of the Securities Act of 1933.	'	'	'	'	'
Common Stock | Three Executive Officers	'	'	'	'	'	'
Equity Issuance Price	$1.24	'	'	'	'	'
Issuance of stock pursuant to employment contracts	8,950,000	'	'	'	'	'
Issuance of stock pursuant to employment contracts, description	'Fifty thousand of the shares were paid directly to one of the officers. The remaining shares will be held by the Company until such time as certain milestones are reached and vesting periods have run. The issuance was exempt from the registration requirements of Section 5 of the Securities Act of 1933 pursuant to Section 4(2) of the Act because there was no public offering in connection with the issuance of the shares.	'	'	'	'	'
Capital Units	'	'	'	'	'	'
Stock sold through private placement	4,520,000	'	'	'	'	'
Equity Issuance Price	$0.50	'	'	'	'	'
Convertible Notes	'	'	'	'	'	'
Stock sold through private placement	1,480,000	'	'	'	'	'

Stockholders_Equity_capital_De3

Stockholders' Equity (capital Deficiency): Assets purchased (Details) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Mar. 31, 2013
Property, Plant and Equipment, Net	$77,696	$48,657	$128
Intangibles (patent, trademarks, URL's)	3,675	3,735	'
Total	'	33,457	'
Craig Ellins	'	'	'
Property, Plant and Equipment, Net	'	$29,722	'

Stock_Option_Plan_Details

Stock Option Plan (Details)	Jun. 30, 2014
Details	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	8,000,000

Subsequent_Events_Details

Subsequent Events (Details) (USD $)

3 Months Ended

12 Months Ended

3 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

1 Months Ended

1 Months Ended

3 Months Ended

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2012

Mar. 31, 2010

Jun. 30, 2014

Jun. 30, 2014

Jul. 31, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jul. 31, 2014

Jun. 30, 2014

Jun. 30, 2014

Notes Payable 1

Craig Ellins

A Warrant

B Warrant

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Convertible Notes

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Notes Payable 1

Craig Ellins

A Warrant

B Warrant

Common Stock

Common Stock

Convertible Notes

Converted notes payable from certain Note Holders into common stock

'

'

$114,013

$1,015,459

'

'

'

'

'

'

'

'

'

$1,015,459

$307,356

'

'

'

'

'

'

Issuance of stock for debt conversions, Shares

'

'

438,681

'

'

'

'

3,905,612

438,681

'

140,000

216,225

'

3,905,612

'

'

'

'

1,202,500

'

'

Stock sold through private placement

'

'

12,500

'

'

'

'

'

1,480,000

1

'

'

1,480,000

'

'

'

'

'

'

'

4,520,000

Warrants, Exercise Price

'

'

'

'

'

$1

$2

'

'

'

'

'

'

'

'

'

$1

$2

'

'

'

Equity Issuance Price

'

'

'

'

'

'

'

$0.50

'

'

'

'

'

'

'

'

'

'

'

$0.50

'

Common stock, shares issued

32,473,282

7,268,948

850,110

'

12,500,000

'

'

'

'

'

'

'

'

'

'

4,000,000

'

'

'

'

'

Proceeds from issuance of stock

$3,579,612

$684,750

'

'

'

'

'

'

'

'

'

'

'

$1,000,000

'

'

'

'

'

'

'

Common Stock issued pursuant to employment contracts

'

'

'

'

'

'

'

'

'

-2,402,682

2,402,682

'

'

8,950,000

'

'

'

'

'

'

'